OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10368	Companies
215924	Keywords
145678	Articles
114359	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 09/01/2025 at 18:00, 8 months 6 days ago

Oxurion bevestigt de vooruitgang van de onderhandelingen over haar strategie voor de diversificatie van de kasmiddelen; closing van de transactie wordt vóór 25 september 2025 verwacht
Oxurion NV (EURONEXT BRUSSEL: OXUR) kündigt positive Finanzierungsgespräche mit Atlas Special Opportunities an. Die Transaktion wird voraussichtlich vor dem 25. September 2025 abgeschlossen sein

Atlas Special Opportunities Oxurion NV Belgien Finanzierungsgespräche Pharmaunternehmen
PRESS RELEASE

published on 09/01/2025 at 18:00, 8 months 6 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications under Belgian legislation from Atlas Special Opportunities II, LLC regarding changes in voting securities holdings

Oxurion NV Belgian Legislation Transparency Notifications Voting Securities Atlas Special Opportunities II LLC
BRIEF

published on 08/07/2025 at 18:05, 9 months ago

Oxurion reçoit des notifications de transparence d'UBS Group AG

Actions Transparence Investisseurs UBS Group AG Oxurion
BRIEF

published on 08/07/2025 at 18:05, 9 months ago

Oxurion receives transparency notifications from UBS Group AG

Investors Actions Transparency UBS Group AG Oxurion
PRESS RELEASE

published on 08/07/2025 at 18:00, 9 months ago

Oxurion ontvangt transparantiekennisgevingen van UBS Group AG
Oxurion NV (Euronext Brussel: OXUR) ontvangt transparantiekennisgevingen van UBS Group AG over aandelentransacties conform Belgische wetgeving. Oxurion, biofarmaceutisch bedrijf in Leuven, België, integreert innovatie en klinisch onderzoekstechnologieën

Transparantiekennisgevingen UBS Group AG Oxurion NV Biofarmaceutisch Belgische Wetgeving
PRESS RELEASE

published on 08/07/2025 at 18:00, 9 months ago

Oxurion beëindigt RD-programma voor geografische maculaire degeneratie en focust op nieuwe CRO-activiteiten
Oxurion beendet präklinisches Forschungsprogramm zur Entwicklung neuer Therapieziele für altersbedingte Makuladegeneration (GA) und fokussiert auf CRO-Aktivitäten und Profitabilität. Integrierte Datenexpertise und externe Expansion im Fokus

Profitabilität Oxurion Präklinisches Forschungsprogramm GA CRO-Aktivitäten
PRESS RELEASE

published on 08/07/2025 at 18:00, 9 months ago

Oxurion Receives Transparency Notifications from UBS Group AG
Oxurion NV received transparency notifications from UBS Group AG regarding share holdings, in compliance with Belgian Transparency legislation. The company is a biopharmaceutical group focusing on therapeutic innovation and clinical research technologies

Clinical Research Biopharmaceutical UBS Group AG Oxurion NV Transparency Notifications
BRIEF

published on 08/06/2025 at 18:05, 9 months 1 day ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF

published on 08/06/2025 at 18:05, 9 months 1 day ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 08/06/2025 at 18:00, 9 months 1 day ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen over aandelentransacties en stimuleert therapeutische innovatie in biofarmaceutica. Zie voor meer informatie www.oxurion.com

Aandelentransacties Transparantiekennisgevingen Oxurion NV Therapeutische Innovatie Biofarmaceutica

Accesswire

Published on 05/07/2026 at 18:30, 1 hour 15 minutes ago

Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 3 hours 10 minutes ago

Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 4 hours 30 minutes ago

ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 14:35, 5 hours 10 minutes ago

Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 5 hours 15 minutes ago

Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 18:46, 59 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 18:35, 1 hour 10 minutes ago

Seminole Hard Rock Casino Named Official Miami World Cup 2026™ Host City Supporter
Published on 05/07/2026 at 18:00, 1 hour 45 minutes ago

Correction d’un communiqué du 05.05.2026 21:46 CET/CEST - E-PANGO: Composition du capital au 30 avril 2026
Published on 05/07/2026 at 17:47, 1 hour 58 minutes ago

RM plc: Result of AGM
Published on 05/07/2026 at 17:45, 2 hours ago

Swiss Life shareholders approve all resolutions proposed by the Board of Directors

Les Echos

Published on 05/07/2026 at 19:15, 30 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 30 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 39 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 39 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 45 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE